Dr. Esposito obtained her Ph.D. in Genetics and Molecular Biology at the University of Rome “La Sapienza”. During this period she worked extensively in antibody engineering and on the development of therapeutic antibodies against viral infections. She completed her postdoctoral training in Cologne, Germany, and then held a position as Investigator. The major focus of her research was on lymphocyte development and antibody maturation. She moved from academia to the pharmaceutical company Organon, where she led an in vivo drug target validation group. At Taconic she established and led the Scientific Project Management and Sales Team with global responsibility for the Custom Model Generation portfolio.